Relay Therapeutics Inc

RLAY · NASDAQ

Biological Product (except Diagnostic) Manufacturing

Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States.

ESG Scores

Overall ESG

5.0

Environmental

6.6

Social

4.2

Governance

4.8

Gender Diversity

Female Directors0.375%

Women in Workforce0.43700000000000006%

CEO GenderMale

Market Data

Price$14.58-0.72 (-4.71%)

Market Cap$3.33B

P/E Ratio—

EPS$—

52W High$17.47

52W Low$2.98

Beta1.72